- 2024-08-20 01:44抑制剂A 922500|A 922500|959122-11-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂A1443|Fluralaner|864731-61-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂7-Methoxyrosmanol|7-Methoxyrosmanol|113085-62-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂A 83-01|A 83-01|909910-43-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂A 83-01|A 83-01|909910-43-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂A 83-01|A 83-01|909910-43-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂7BIO|7BIO|916440-85-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂7BIO|7BIO|916440-85-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂7-Methoxyrosmanol|7-Methoxyrosmanol|113085-62-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂7-Methoxyrosmanol|7-Methoxyrosmanol|113085-62-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂6-Hydroxyindole|6-Hydroxyindole|2380-86-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:43抑制剂6-Hydroxyindole|6-Hydroxyindole|2380-86-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂6-Hydroxyindole|6-Hydroxyindole|2380-86-1|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:43抑制剂7BIO|7BIO|916440-85-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:43抑制剂5'-O-DMT-2'-O-iBu-N-Bz-Guanosine|5'-O-DMT-2'-O-iBu-N-Bz-Guanosine|81279-39-2|
- 2024-08-20 01:43抑制剂5'-O-DMT-2'-O-iBu-N-Bz-Guanosine|5'-O-DMT-2'-O-iBu-N-Bz-Guanosine|81279-39-2|
- 2024-08-20 01:43抑制剂5-HT3 antagonist 5|5-HT3 antagonist 5|901599-43-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:43抑制剂5-Carboxamidotryptamine maleate|5-Carboxamidotryptamine maleate|74885-72-6|Adamas life|≥98%（以实测数值
- 2024-08-20 01:43抑制剂5-HT3 antagonist 5|5-HT3 antagonist 5|901599-43-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:43抑制剂5-HT3 antagonist 5|5-HT3 antagonist 5|901599-43-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
